For every $1 we spend in seed funding through the Future Leaders in Canadian Brain Research program, Future Leaders will attract an additional $7.75 to build on their findings.
For every $1 we spend in seed funding through the Future Leaders in Canadian Brain Research program, Future Leaders will attract an additional $7.75 to build on their findings. Since 2019, the Future Leaders program has supported 131 promising early career researchers with $100,000 each to pursue bold ideas, advance their research programs, and launch their careers. This seed funding has allowed Future Leaders to:
Brain Canada and ALS Society of Canada (ALS Canada) are proud to announce six Canadian research teams receiving funding through the 2025 ALS Canada–Brain Canada Discovery Grants, a $1.5 million investment supporting projects designed to deepen scientific understanding of amyotrophic lateral sclerosis (ALS) and accelerate the development of potential treatments.
The 2025 Clinical Research Fellowship and Trainee Awards
Brain Canada and The ALS Society of Canada (ALS Canada) are proud to announce the recipients of the 2025 ALS Canada–Brain Canada Clinical Research Fellowship and Trainee Awards.
In 2020, Olivier Goy, an entrepreneur, activist and photography lover from France, was diagnosed with amyotrophic lateral sclerosis (ALS) – a rare neurodegenerative disease that can have many different underlying causes, presentations, and prognoses. Some patients may live with the disease for decades, while others decline rapidly.
Could a ketogenic diet slow the progression of ALS?
“Increase your caloric intake.” This is the number one recommendation that a clinician will make to a person recently diagnosed with Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease affecting nerve cells in the brain and spinal cord, causing loss of muscle control. A high calorie diet is linked to better outcomes for ALS patients, but the question is – why? And what is the optimum diet to slow progression of the disease?
Reprogramming cells to replace neurons damaged by ALS?
Meet the junior researchers behind the 2022 ALS Canada – Brain Canada Trainee Awards. Dr. Hussein Ghazale is the recipient of a $165,000 ALS Canada – Brain Canada 2022 Trainee Award.
Meet the students who received the 2022 ALS Canada – Brain Canada Doctoral Awards. PhD student Lucia Meng Qi Jadon (previously Liao) is the recipient of a $75,000 ALS Canada – Brain Canada 2022 Trainee Award. She will use the funding to investigate whether a newly discovered tag on TDP-43 might have an important role to play in ALS.
Meet the students behind the 2022 ALS Canada – Brain Canada Trainee Awards. Charlotte Manser is the recipient of a $75,000 ALS Canada – Brain Canada 2022 Trainee Award. As a PhD student at the University of Ottawa, she investigates how ALS-linked genes might contribute to the loss of normal stress granule formation.
International student explores understudied causes of ALS
Meet the junior researchers who received the 2022 ALS Canada – Brain Canada Trainee Awards. Donovan McDonald is the recipient of a $75,000 ALS Canada – Brain Canada 2022 Trainee Award. As a PhD student, he investigates how the function of tRNA could contribute to ALS disease processes.
Future change-maker in ALS pursues innovative research
Meet the students behind the 2022 ALS Canada – Brain Canada Trainee Awards. Charlotte Manser is the recipient of a $75,000 ALS Canada – Brain Canada 2022 Trainee Award. As a PhD student at the University of Ottawa, she investigates how ALS-linked genes might contribute to the loss of normal stress granule formation.
Dr. Alex Parker, at the Centre de recherche du CHUM, Université de Montreal, is one of the first two recipients of the newly introduced three-year, $300,000 ALS Canada–Brain Canada Discovery Grant. Dr. Parker’s grant was funded in generous partnership with Dr. Jean-Pierre Canuel Fund – SLA Québec.
